Fully Biodegradable Coronary Stents

Steve Ramcharitar; Patrick W. Serruys

doi:10.2165/00129784-200808050-00003

Article2002

Sirolimus‐Eluting Coronary Stents

Pim J. de Feyter, Peter Smits, Benno J. Rensing, J. Vos, Willem J. van der Giessen, Georgios Sianos, Patrick W. Serruys

Journal of Interventional Cardiology

Letter2008

Drug-Eluting Stents vs. Coronary-Artery Bypass Grafting

Joost Daemen, Neville Kukreja, Patrick W. Serruys

New England Journal of Medicine

Article2013

New concepts in the design of drug-eluting coronary stents

Scot Garg, Christos V. Bourantas, Patrick W. Serruys

Nature Reviews Cardiology

Article2013

TCT-836 The impact of biodegradable versus durable polymer drug-eluting stents on stent thrombosis in patients with coronary artery disease: a meta-analysis of 15 randomized trials

Yao‐Jun Zhang, Javaid Iqbal, Christos V. Bourantas, Shaoliang Chen, Héctor M. García‐García, Takashi Muramatsu, Patrick W. Serruys, Dong Sheng-Jie, Bo Xu

Journal of the American College of Cardiology

Article2014

NOBORI™ biodegradable-polymer biolimus-eluting stent versus durable-polymer drug-eluting stents: A meta-analysis

Yao‐Jun Zhang, Fei Ye, Javaid Iqbal, Shengjie Dong, Christos V. Bourantas, Nai‐Liang Tian, Patrick W. Serruys, Shao-Liang Chen

International Journal of Cardiology

Fully Biodegradable Coronary Stents

Abstract

Discussion(0)

Related publications

Sirolimus‐Eluting Coronary Stents

Drug-Eluting Stents vs. Coronary-Artery Bypass Grafting

New concepts in the design of drug-eluting coronary stents

TCT-836 The impact of biodegradable versus durable polymer drug-eluting stents on stent thrombosis in patients with coronary artery disease: a meta-analysis of 15 randomized trials

NOBORI™ biodegradable-polymer biolimus-eluting stent versus durable-polymer drug-eluting stents: A meta-analysis